These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 5727310)

  • 1. [Serum levels of insulin in the normal subject (obese and non-obese) and in the obese diabetic after intragastric administration of amino acids].
    Laudicina E; Bompiani G; Angileri G
    Acta Diabetol Lat; 1968; 5(1):64-79. PubMed ID: 5727310
    [No Abstract]   [Full Text] [Related]  

  • 2. [Intragastric administration of amino acids and the insulo-pancreatic response in normal subjects and obese diabetics].
    Laudicina E; Bompiani GD; Angileri G
    Folia Endocrinol; 1967 Feb; 20(1):108-18. PubMed ID: 6072419
    [No Abstract]   [Full Text] [Related]  

  • 3. Study of plasma insulin and glucose profile in obese and non-obese normal controls and diabetic subjects.
    Aslam M; ud Din F; Obaidullah S; Haider Z
    J Pak Med Assoc; 1981 Feb; 31(2):39-42. PubMed ID: 6785485
    [No Abstract]   [Full Text] [Related]  

  • 4. Glucose disposal in obese non-diabetic and diabetic type II patients. A study by indirect calorimetry and euglycemic insulin clamp.
    Golay A; Defronzo RA; Thorin D; Jequier E; Felber JP
    Diabete Metab; 1988; 14(4):443-51. PubMed ID: 3066652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [NEFA behavior and its correlations with IRI during IVGTT in normal, obese and diabetic subjects].
    Cordera R; De Micheli A; Maiello M; Odetti P; Viviani G; Prando R; Adezati L
    Minerva Dietol Gastroenterol; 1979; 25(3):347-52. PubMed ID: 400005
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasma insulin and glucose profiles in normal, obese, and diabetic persons.
    Genuth SM
    Ann Intern Med; 1973 Dec; 79(6):812-22. PubMed ID: 4761908
    [No Abstract]   [Full Text] [Related]  

  • 7. [Circadian variations of IRI, during fasting, in normal, obese and diabetic subjects].
    Cucinotta D; Quartarone M; Saitta A; Miceli A; Squadrito G
    Minerva Med; 1979 May; 70(23):1659-66. PubMed ID: 450306
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of amino acids on the secretion of growth hormone and insulin in healthy persons and diabetics].
    Waldhäusl W; Beringer A
    Klin Wochenschr; 1969 Apr; 47(7):359-63. PubMed ID: 5383388
    [No Abstract]   [Full Text] [Related]  

  • 9. [Immunologically measurable insulin(IMI) in normal, obese and obese, diabetic subjects after intravenous administration of glucose, tolbutamide and glucagon].
    Melani F; Lawecki J; Bartelt KM; Pfeiffer EF
    Diabetologia; 1967 Oct; 3(5):422-6. PubMed ID: 5620801
    [No Abstract]   [Full Text] [Related]  

  • 10. [Plasma glucagon and insulin profile in obese non-diabetic and non-insulin-dependent diabetic patients on a daily 800 calorie diet].
    Balázsi I; Varsányi-Nagy M; Nagy K
    Orv Hetil; 1986 Aug; 127(33):2009-13. PubMed ID: 3537903
    [No Abstract]   [Full Text] [Related]  

  • 11. Plasma insulin, cholecystokinin, galanin, neuropeptide Y and leptin levels in obese women with and without type 2 diabetes mellitus.
    Milewicz A; Mikulski E; Bidzińska B
    Int J Obes Relat Metab Disord; 2000 Jun; 24 Suppl 2():S152-3. PubMed ID: 10997641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Free plasma amino acids in obese persons].
    Bertolini AM; Santagostino A
    Minerva Med; 1973 May; 64(32):1718-23. PubMed ID: 4713750
    [No Abstract]   [Full Text] [Related]  

  • 13. Acute and chronic effects of dexfenfluramine on glucose and insulin response to intravenous glucose in diabetic and non-diabetic obese subjects.
    Glaser B; Raveh Y; Norynberg C; Berry E; Lavielle R; Nathan C; Cerasi E
    Diabetes Res; 1992; 19(4):165-76. PubMed ID: 1343113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling blood glucose and insulin kinetics in normal, diabetic and obese subjects.
    Segre G; Turco GL; Vercellone G
    Diabetes; 1973 Feb; 22(2):94-103. PubMed ID: 4687648
    [No Abstract]   [Full Text] [Related]  

  • 15. Metformin normalizes insulin binding to monocytes from obese nondiabetic subjects and obese type II diabetic patients.
    Trischitta V; Gullo D; Pezzino V; Vigneri R
    J Clin Endocrinol Metab; 1983 Oct; 57(4):713-8. PubMed ID: 6350337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of muscular exercise on plasma C-peptide and insulin in obese non-diabetics and diabetics, type II.
    Krotkiewski M; Górski J
    Clin Physiol; 1986 Dec; 6(6):499-506. PubMed ID: 3539463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for diminished brain 5-hydroxytryptamine biosynthesis in obese diabetic and non-diabetic humans.
    Ashley DV; Fleury MO; Golay A; Maeder E; Leathwood PD
    Am J Clin Nutr; 1985 Dec; 42(6):1240-5. PubMed ID: 3907326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radioimmunoassay of insulin in plasma and urine in obese subjects and in diabetic patients.
    Jorgensen KR
    Acta Endocrinol (Copenh); 1969 Apr; 60(4):719-36. PubMed ID: 4890967
    [No Abstract]   [Full Text] [Related]  

  • 19. Influence of obesity on basal glucagon levels in non-diabetic and diabetic Nauruans.
    Alford FP; Zimmet P; Chisholm DJ; Whitehouse S
    Clin Endocrinol (Oxf); 1983 Dec; 19(6):721-5. PubMed ID: 6360432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracellular hyperinsulinism: a metabolic characteristic of obesity with and without Type 2 diabetes: intracellular insulin in obesity and Type 2 diabetes.
    Benzi L; Ciccarone AM; Cecchetti P; DiCianni G; Caricato F; Trincavelli L; Volpe L; Navalesi R
    Diabetes Res Clin Pract; 1999 Dec; 46(3):231-7. PubMed ID: 10624789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.